The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Cytarabine 100 mg/ml Solution for Injection

Pfizer Healthcare IrelandPA0822/200/002

Main Information

Trade NameCytarabine 100 mg/ml Solution for Injection
Active SubstancesCytarabine
Dosage FormSolution for injection
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/200/002

Group Information

ATC CodeL01BC Pyrimidine analogues
L01BC01 cytarabine


License statusAuthorised
Licence Issued21/05/1990
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back